Evidence map›Paper›PMID 28611480›Full record

ReviewNature reviews. Gastroenterology & hepatology2017

Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics.

Glenn R Gibson, Robert Hutkins, Mary Ellen Sanders, Susan L Prescott, Raylene A Reimer, Seppo J Salminen, Karen Scott, Catherine Stanton, Kelly S Swanson, Patrice D Cani and 2 more

6 registry-linked trialsAbstract readConsensus StatementReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Gastroenterology & hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 2,338 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,338citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04534036 nacompletednot on this mapstarted 2020, after this paper: background citation

A 12-week Randomized, Double-Blind Controlled Trial to Evaluate the Tolerability and Gastrointestinal Response of a Novel, Multi-Strain Synbiotic (PDS-08™) in Children Ages 3-17

TypeinterventionalSponsorSeed HealthRan2020 to 2022Enrolled64ConditionsConstipation, Signs and Symptoms, Digestive Signs and Symptoms, Infrequent or Difficult EvacuationArmsPDS-08, Placebo
NCT05689684 nacompletednot on this mapstarted 2022, after this paper: background citation

Arabinoxylan-oligosaccharides (AXOS) As a Medical Food for Adjuvant Approach in the Management of Type-2 Diabetes

TypeinterventionalSponsorLund UniversityRan2022 to 2024Enrolled66ConditionsDiabetes Type 2ArmsAG+XOS+AXOS, Placebo Maltodextrin
NCT06030999 nacompletednot on this mapstarted 2023, after this paper: background citation

Three Arms, Randomized, Double-blind Controlled Trial Of Prevention And Treatment On Obesity And Weight Management By Oral Supplementation Of Probiotics And Prebiotics

TypeinterventionalSponsorShenzhen Precision Health Food Technology Co. Ltd.,Ran2023 to 2023Enrolled150ConditionsOverweight and ObesityArmsStudy product A (Wonderlab wonder4shape), Study product B (Wonderlab wonder4shape), Study product C (placebo)
NCT06611215 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

A Randomized, Double Blind, Placebo-controlled, Parallel Study to Investigate the Effect of Prebiotic Supplements on Gut Microbiota Modulation and Quality of Life.

TypeinterventionalSponsorPharmavite LLCRan2024 to 2025Enrolled80ConditionsChanges in Gut Microbiota with Prebiotic Supplementation, Quality of LifeArmsTreatment, Placebo
NCT06825117 naenrolling by invitationnot on this mapstarted 2024, after this paper: background citation

Impact of Probiotic Supplementation on Urinary Tract Infections and Clinically Relevant Outcomes of Kidney Transplant Recipients

TypeinterventionalSponsorUniversity Hospital, Udine, ItalyRan2024 to 2028Enrolled132ConditionsUrinary Tract Infections, Kidney Transplant Rejection, Kidney Transplant Infection, DysbiosisArmsOMNi-BiOTiC® 41167, Placebo
NCT07443410 narecruitingnot on this mapstarted 2024, after this paper: background citation

Microbiological and Clinical Effects of Pre- and Probiotics in Non-Surgical Periodontal Therapy

TypeinterventionalSponsorUniversity Hospital HeidelbergRan2024 to 2026Enrolled60ConditionsPeriodontitis, Adult, Periodontitis (Stage 3), Periodontitis Stage IVArmsNon-surgical periodontal therapy (NSPT) and supportive periodontal therapy (SPT), Probiotic lozenge (Limosilactobacillus reuteri, GUM® PerioBalance®), Vitamin B12 drops (natural elements)
3 · Its place in the literature

Who cites it

2,338 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Prebiotic Administration to Chronic Kidney Disease Patients Modifies Their Fecal Microbiome and Host Metabolism.Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2026
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Review
  19. Review
  20. Article

2,278 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Glenn R GibsonDepartment of Food and Nutritional Sciences, The University of Reading, Whiteknights, PO Box 226, Reading RG6 6AP, UK.
Robert HutkinsDepartment of Food Science and Technology, 258 Food Innovation Center, University of Nebraska - Lincoln, Lincoln, Nebraska 68588-6205, USA.
Mary Ellen SandersInternational Scientific Association for Probiotics and Prebiotics, 7119 S. Glencoe Court, Centennial, Colorado 80122, USA.
Susan L PrescottSchool of Paediatrics and Child Health, The University of Western Australia, 35 Stirling Highway, Perth, WA 6009, Australia.
Raylene A ReimerFaculty of Kinesiology and Department of Biochemistry and Molecular Biology, 2500 University Drive, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Seppo J SalminenFunctional Foods Forum, Faculty of Medicine, Itäinen Pitkäkatu 4A, FI-20014, University of Turku, Turku 20014, Finland.
Karen ScottRowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, AB21 9SB, UK.
Catherine StantonTeagasc Moorepark Food Research Centre, Fermoy, Cork, P61 C996, Ireland.
Kelly S SwansonDepartment of Animal Sciences, University of Illinois at Urbana-Champaign, 1207 W Gregory Drive, Urbana, Illinois 61801, USA.
Patrice D CaniUniversité catholique de Louvain, Louvain Drug Research Institute, 73 Avenue E Mounier, WELBIO (Walloon Excellence in Life Sciences and Biotechnology), Metabolism and Nutrition Research Group, 1200 Brussels, Belgium.
Kristin VerbekeTranslational Research in Gastrointestinal Disorders, KU Leuven, Targid - Herestraat 49, Leuven, Belgium and Leuven Food Science and Nutrition Research Centre, BE 3001, Leuven, Belgium.
Gregor ReidLawson Health Research Institute, University of Western Ontario, 268 Grosvenor Street, London, Ontario, N6A 4V2, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In December 2016, a panel of experts in microbiology, nutrition and clinical research was convened by the International Scientific Association for Probiotics and Prebiotics to review the definition and scope of prebiotics. Consistent with the original embodiment of prebiotics, but aware of the latest scientific and clinical developments, the panel updated the definition of a prebiotic: a substrate that is selectively utilized by host microorganisms conferring a health benefit. This definition expands the concept of prebiotics to possibly include non-carbohydrate substances, applications to body sites other than the gastrointestinal tract, and diverse categories other than food. The requirement for selective microbiota-mediated mechanisms was retained. Beneficial health effects must be documented for a substance to be considered a prebiotic. The consensus definition applies also to prebiotics for use by animals, in which microbiota-focused strategies to maintain health and prevent disease is as relevant as for humans. Ultimately, the goal of this Consensus Statement is to engender appropriate use of the term 'prebiotic' by relevant stakeholders so that consistency and clarity can be achieved in research reports, product marketing and regulatory oversight of the category. To this end, we have reviewed several aspects of prebiotic science including its development, health benefits and legislation.

Indexed as

PrebioticsHumansProbioticsSocieties, ScientificTerminology as TopicPrebiotics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.